Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02632448
Title A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Esperas Pharma Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | HRV | CAN

Facility Status City State Zip Country Details
Dana Farber Cancer Institute COMPLETED Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute COMPLETED Detroit Michigan 48201 United States Details
Tom Baker Cancer Centre RECRUITING Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
BC Cancer Agency RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Ottawa Hospital Cancer Centre COMPLETED Ottawa Ontario K1H 8L6 Canada Details
University Health Network - Princess Margaret Hospital RECRUITING Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
McGill University Health Centre RECRUITING Montreal Quebec H4A 3J1 Canada Details
Centre Hospitalier de l'Université de Montréal RECRUITING Montréal Quebec H2X 0A9 Canada Details
General Hospital Zadar RECRUITING Zadar 23000 Croatia Details
University Hospital Centre Zagreb RECRUITING Zagreb 10000 Croatia Details
Centrum Onkologii im. prof. F. Łukaszczyka RECRUITING Bydgoszcz 85-796 Poland Details
Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz RECRUITING Gdańsk 80-214 Poland Details
Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o. o. RECRUITING Kraków 30-348 Poland Details
Szpital Specjalistyczny im. L. Rydygiera w Krakowie sp. z o. o. RECRUITING Kraków 31-826 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field